Gilead Sciences Inc diskutieren
Gilead Sciences Inc
WKN: 885823 / Symbol: GILD / Name: Gilead Sciences / Aktie / Biotechnologie & medizinische Forschung / Large Cap /
128,32 €
1,78 %
Gilead Sciences (NASDAQ:GILD) had its price target raised by analysts at Leerink Partners from $146.00 to $148.00. They now have an "outperform" rating on the stock.
Ratings data for GILD provided by MarketBeat
Gilead Sciences (NASDAQ:GILD) had its price target raised by analysts at Rothschild & Co Redburn from $159.00 to $170.00. They now have a "buy" rating on the stock.
Ratings data for GILD provided by MarketBeat
Gilead Sciences (NASDAQ:GILD) had its price target raised by analysts at Mizuho from $140.00 to $170.00. They now have an "outperform" rating on the stock.
Ratings data for GILD provided by MarketBeat
Gilead Sciences (NASDAQ:GILD) had its price target raised by analysts at Argus from $135.00 to $165.00. They now have a "buy" rating on the stock.
Ratings data for GILD provided by MarketBeat
Gilead Sciences (NASDAQ:GILD) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $170.00 price target on the stock.
Ratings data for GILD provided by MarketBeat
Gilead Sciences (GILD) had its price target raised by Daiwa Securities Group Inc. from $129.00 to $161.00. They now have an "outperform" rating on the stock.
Ratings data for GILD provided by MarketBeat
Neueste Beiträge
StockNews_com in Compañía de Minas Buenaventura S.A.A. ADR diskutieren